Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 05/6/15 → 05/5/18 |
Funding
- Astellas Pharma Global Development Incorporated: $9,000.00
A Phase 4, Double-Blind, Randomized, Placebo-Contolled, Parallel Group, Multi-Center Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Older Adult Subjects with Overactive Bladder (OAB)
- Ablove, Tova (PI)
- Danforth, Teresa (CoI)
Project: Research